{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:29:49Z","timestamp":1790281789416,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,5,30]],"date-time":"2018-05-30T00:00:00Z","timestamp":1527638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Stiftelsen Sj\u00f6grens syndrom"},{"DOI":"10.13039\/501100006075","name":"Greta och Johan Kocks stiftelser","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006075","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007949","name":"Reumatikerf\u00f6rbundet","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007949","id-type":"DOI","asserted-by":"crossref"}]},{"name":"ALF Sk\u00e5ne"},{"name":"Internal Research Funds of Sk\u00e5ne University Hospital"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s00296-018-4063-8","type":"journal-article","created":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T17:31:57Z","timestamp":1545240717000},"page":"1503-1510","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Smoking, disease characteristics and serum cytokine levels in patients with primary Sj\u00f6gren\u2019s syndrome"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7318-833X","authenticated-orcid":false,"given":"Peter","family":"Olsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0026-3711","authenticated-orcid":false,"given":"Kristin","family":"Skogstrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3805-2290","authenticated-orcid":false,"given":"Carl","family":"Turesson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennart T. H.","family":"Jacobsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Theander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5948-4156","authenticated-orcid":false,"given":"Gunnar","family":"Houen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7143-7088","authenticated-orcid":false,"given":"Thomas","family":"Mandl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,30]]},"reference":[{"issue":"4","key":"4063_CR1","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/00005792-200207000-00003","volume":"81","author":"M Garcia-Carrasco","year":"2002","unstructured":"Garcia-Carrasco M, Ramos-Casals M, Rosas J, Pallares L, Calvo-Alen J, Cervera R et al (2002) Primary Sjogren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients. Medicine (Baltimore) 81(4):270\u2013280","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"4063_CR2","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/rheumatology\/ket349","volume":"53","author":"M Ramos-Casals","year":"2014","unstructured":"Ramos-Casals M, Brito-Zeron P, Solans R, Camps MT, Casanovas A, Sopena B et al (2014) Systemic involvement in primary Sjogren\u2019s syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 Spanish patients (GEAS-SS Registry). Rheumatology 53(2):321\u2013331","journal-title":"Rheumatology"},{"issue":"9","key":"4063_CR3","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nrrheum.2013.110","volume":"9","author":"G Nocturne","year":"2013","unstructured":"Nocturne G, Mariette X (2013) Advances in understanding the pathogenesis of primary Sjogren\u2019s syndrome. Nat Rev Rheumatol 9(9):544\u2013556","journal-title":"Nat Rev Rheumatol"},{"issue":"5001","key":"4063_CR4","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1136\/bmj.2.5001.1071","volume":"2","author":"R Doll","year":"1956","unstructured":"Doll R, Hill AB (1956) Lung cancer and other causes of death in relation to smoking; a second report on the mortality of British doctors. Br Med J 2(5001):1071\u20131081","journal-title":"Br Med J"},{"issue":"10","key":"4063_CR5","first-page":"1067","volume":"111","author":"RW Morgan","year":"1974","unstructured":"Morgan RW, Jain MG (1974) Bladder cancer: smoking, beverages and artificial sweeteners. Can Med Assoc J 111(10):1067\u20131070","journal-title":"Can Med Assoc J"},{"issue":"6077","key":"4063_CR6","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1136\/bmj.1.6077.1645","volume":"1","author":"C Fletcher","year":"1977","unstructured":"Fletcher C, Peto R (1977) The natural history of chronic airflow obstruction. Br Med J 1(6077):1645\u20131648","journal-title":"Br Med J"},{"issue":"11","key":"4063_CR7","doi-asserted-by":"publisher","first-page":"520","DOI":"10.4103\/0019-5359.58884","volume":"63","author":"DS Prasad","year":"2009","unstructured":"Prasad DS, Kabir Z, Dash AK, Das BC (2009) Smoking and cardiovascular health: a review of the epidemiology, pathogenesis, prevention and control of tobacco. Indian J Med Sci 63(11):520\u2013533","journal-title":"Indian J Med Sci"},{"issue":"1","key":"4063_CR8","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1136\/ard.2008.096487","volume":"69","author":"D Sugiyama","year":"2010","unstructured":"Sugiyama D, Nishimura K, Tamaki K, Tsuji G, Nakazawa T, Morinobu A et al (2010) Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis 69(1):70\u201381","journal-title":"Ann Rheum Dis"},{"issue":"5 Suppl 24","key":"4063_CR9","first-page":"S77","volume":"19","author":"SW Rizvi","year":"2001","unstructured":"Rizvi SW, McGrath H Jr. (2001) The therapeutic effect of cigarette smoking on oral\/genital aphthosis and other manifestations of Behcet\u2019s disease. Clin Exp Rheumatol 19(5 Suppl 24):S77\u2013S78","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"4063_CR10","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1007\/BF01536701","volume":"34","author":"BM Calkins","year":"1989","unstructured":"Calkins BM (1989) A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci 34(12):1841\u20131854","journal-title":"Dig Dis Sci"},{"issue":"4","key":"4063_CR11","doi-asserted-by":"publisher","first-page":"e95297","DOI":"10.1371\/journal.pone.0095297","volume":"9","author":"M Mark van der","year":"2014","unstructured":"van der Mark M, Nijssen PC, Vlaanderen J, Huss A, Mulleners WM, Sas AM et al (2014) A case-control study of the protective effect of alcohol, coffee, and cigarette consumption on Parkinson disease risk: time-since-cessation modifies the effect of tobacco smoking. PLoS One 9(4):e95297","journal-title":"PLoS One"},{"issue":"3","key":"4063_CR12","doi-asserted-by":"publisher","first-page":"J258","DOI":"10.1016\/j.jaut.2009.12.003","volume":"34","author":"Y Arnson","year":"2010","unstructured":"Arnson Y, Shoenfeld Y, Amital H (2010) Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun 34(3):J258\u2013J265","journal-title":"J Autoimmun"},{"issue":"5","key":"4063_CR13","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nri803","volume":"2","author":"M Sopori","year":"2002","unstructured":"Sopori M (2002) Effects of cigarette smoke on the immune system. Nat Rev Immunol 2(5):372\u2013377","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"4063_CR14","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1136\/ard.59.1.54","volume":"59","author":"R Manthorpe","year":"2000","unstructured":"Manthorpe R, Benoni C, Jacobsson L, Kirtava Z, Larsson A, Liedholm R et al (2000) Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA\/Ro and anti-SSB\/La antibodies in Sjogren\u2019s syndrome? Ann Rheum Dis 59(1):54\u201360","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"4063_CR15","doi-asserted-by":"publisher","first-page":"602","DOI":"10.3109\/s10165-011-0446-3","volume":"21","author":"G Karabulut","year":"2011","unstructured":"Karabulut G, Kitapcioglu G, Inal V, Kalfa M, Yargucu F, Keser G et al (2011) Cigarette smoking in primary Sjogren\u2019s syndrome: positive association only with ANA positivity. Mod Rheumatol 21(6):602\u2013607","journal-title":"Mod Rheumatol"},{"issue":"2","key":"4063_CR16","doi-asserted-by":"publisher","first-page":"e0170249","DOI":"10.1371\/journal.pone.0170249","volume":"12","author":"DU Stone","year":"2017","unstructured":"Stone DU, Fife D, Brown M, Earley KE, Radfar L, Kaufman CE et al (2017) Effect of tobacco smoking on the clinical, histopathological, and serological manifestations of Sjogren\u2019s syndrome. PLoS One 12(2):e0170249","journal-title":"PLoS One"},{"issue":"1","key":"4063_CR17","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13075-017-1255-7","volume":"19","author":"P Olsson","year":"2017","unstructured":"Olsson P, Turesson C, Mandl T, Jacobsson L, Theander E (2017) Cigarette smoking and the risk of primary Sjogren\u2019s syndrome: a nested case control study. Arthritis Res Ther 19(1):50","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"4063_CR18","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/j.0300-9475.2005.01540.x","volume":"61","author":"A Larsson","year":"2005","unstructured":"Larsson A, Bredberg A, Henriksson G, Manthorpe R, Sallmyr A (2005) Immunohistochemistry of the B-cell component in lower lip salivary glands of Sjogren\u2019s syndrome and healthy subjects. Scand J Immunol 61(1):98\u2013107","journal-title":"Scand J Immunol"},{"issue":"5","key":"4063_CR19","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1080\/03009740902973821","volume":"38","author":"R Baturone","year":"2009","unstructured":"Baturone R, Soto MJ, Marquez M, Macias I, de Oca MM, Medina F et al (2009) Health-related quality of life in patients with primary Sjogren\u2019s syndrome: relationship with serum levels of proinflammatory cytokines. Scand J Rheumatol 38(5):386\u2013389","journal-title":"Scand J Rheumatol"},{"issue":"9","key":"4063_CR20","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1093\/rheumatology\/kep149","volume":"48","author":"TR Reksten","year":"2009","unstructured":"Reksten TR, Jonsson MV, Szyszko EA, Brun JG, Jonsson R, Brokstad KA (2009) Cytokine and autoantibody profiling related to histopathological features in primary Sjogren\u2019s syndrome. Rheumatology 48(9):1102\u20131106","journal-title":"Rheumatology"},{"issue":"6","key":"4063_CR21","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE et al (2002) Classification criteria for Sjogren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61(6):554\u2013558","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"4063_CR22","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/annrheumdis-2013-204615","volume":"74","author":"R Seror","year":"2015","unstructured":"Seror R, Theander E, Brun JG, Ramos-Casals M, Valim V, Dorner T et al (2015) Validation of EULAR primary Sjogren\u2019s syndrome disease activity (ESSDAI) and patient indexes (ESSPRI). Ann Rheum Dis 74(5):859\u2013866","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"4063_CR23","doi-asserted-by":"publisher","first-page":"464","DOI":"10.3899\/jrheum.140370","volume":"42","author":"AM Nilsson","year":"2015","unstructured":"Nilsson AM, Diaz S, Theander E, Hesselstrand R, Piitulainen E, Ekberg O et al (2015) Chronic obstructive pulmonary disease is common in never-smoking patients with primary Sjogren syndrome. J Rheumatol 42(3):464\u2013471","journal-title":"J Rheumatol"},{"issue":"5","key":"4063_CR24","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1164\/ajrccm.163.5.2101039","volume":"163","author":"RA Pauwels","year":"2001","unstructured":"Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS, Committee GS (2001) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI\/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 163(5):1256\u20131276","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"4063_CR25","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3109\/00365513.2014.965738","volume":"75","author":"BE Holm","year":"2015","unstructured":"Holm BE, Sandhu N, Tronstrom J, Lydolph M, Trier NH, Houen G (2015) Species cross-reactivity of rheumatoid factors and implications for immunoassays. Scand J Clin Lab Investig 75(1):51\u201363","journal-title":"Scand J Clin Lab Investig"},{"issue":"1","key":"4063_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/03009742.2016.1161070","volume":"46","author":"P Olsson","year":"2017","unstructured":"Olsson P, Theander E, Bergstrom U, Jovinge S, Jacobsson L, Turesson C (2017) Multiplex cytokine analyses in patients with rheumatoid arthritis require use of agents blocking heterophilic antibody activity. Scand J Rheumatol 46(1):1\u201310","journal-title":"Scand J Rheumatol"},{"issue":"4","key":"4063_CR27","first-page":"110","volume":"4","author":"M Rad","year":"2010","unstructured":"Rad M, Kakoie S, Niliye Brojeni F, Pourdamghan N (2010) Effect of long-term smoking on whole-mouth salivary flow rate and oral health. J Dent Res Dent Clin Dent Prospects 4(4):110\u2013114","journal-title":"J Dent Res Dent Clin Dent Prospects"},{"issue":"4","key":"4063_CR28","doi-asserted-by":"publisher","first-page":"309","DOI":"10.15644\/asc49\/4\/6","volume":"49","author":"N Petrusic","year":"2015","unstructured":"Petrusic N, Posavac M, Sabol I, Mravak-Stipetic M (2015) The effect of tobacco smoking on salivation. Acta Stomatol Croat 49(4):309\u2013315","journal-title":"Acta Stomatol Croat"},{"issue":"5","key":"4063_CR29","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.4049\/jimmunol.1102552","volume":"188","author":"M Nouri-Shirazi","year":"2012","unstructured":"Nouri-Shirazi M, Guinet E (2012) Exposure to nicotine adversely affects the dendritic cell system and compromises host response to vaccination. J Immunol 188(5):2359\u20132370","journal-title":"J Immunol"},{"issue":"5","key":"4063_CR30","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.tiv.2011.03.011","volume":"25","author":"SM Castro","year":"2011","unstructured":"Castro SM, Chakraborty K, Guerrero-Plata A (2011) Cigarette smoke suppresses TLR-7 stimulation in response to virus infection in plasmacytoid dendritic cells. Toxicol In Vitro 25(5):1106\u20131113","journal-title":"Toxicol In Vitro"},{"issue":"2","key":"4063_CR31","doi-asserted-by":"publisher","first-page":"R51","DOI":"10.1186\/ar1912","volume":"8","author":"M Ittah","year":"2006","unstructured":"Ittah M, Miceli-Richard C, Eric Gottenberg J, Lavie F, Lazure T, Ba N et al (2006) B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjogren\u2019s syndrome. Arthritis Res Ther 8(2):R51","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"4063_CR32","doi-asserted-by":"publisher","first-page":"3977","DOI":"10.1002\/art.23073","volume":"56","author":"MN Manoussakis","year":"2007","unstructured":"Manoussakis MN, Boiu S, Korkolopoulou P, Kapsogeorgou EK, Kavantzas N, Ziakas P et al (2007) Rates of infiltration by macrophages and dendritic cells and expression of interleukin-18 and interleukin-12 in the chronic inflammatory lesions of Sjogren\u2019s syndrome: correlation with certain features of immune hyperactivity and factors associated with high risk of lymphoma development. Arthritis Rheumatol 56(12):3977\u20133988","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"4063_CR33","doi-asserted-by":"publisher","first-page":"R22","DOI":"10.1186\/ar2375","volume":"10","author":"N Delaleu","year":"2008","unstructured":"Delaleu N, Immervoll H, Cornelius J, Jonsson R (2008) Biomarker profiles in serum and saliva of experimental Sjogren\u2019s syndrome: associations with specific autoimmune manifestations. Arthritis Res Ther 10(1):R22","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"4063_CR34","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1046\/j.1365-3083.1999.00533.x","volume":"49","author":"A Halse","year":"1999","unstructured":"Halse A, Tengner P, Wahren-Herlenius M, Haga H, Jonsson R (1999) Increased frequency of cells secreting interleukin-6 and interleukin-10 in peripheral blood of patients with primary Sjogren\u2019s syndrome. Scand J Immunol 49(5):533\u2013538","journal-title":"Scand J Immunol"},{"issue":"4","key":"4063_CR35","first-page":"411","volume":"19","author":"M Garcic-Carrasco","year":"2001","unstructured":"Garcic-Carrasco M, Font J, Filella X, Cervera R, Ramos-Casals M, Siso A et al (2001) Circulating levels of Th1\/Th2 cytokines in patients with primary Sjogren\u2019s syndrome: correlation with clinical and immunological features. Clin Exp Rheumatol 19(4):411\u2013415","journal-title":"Clin Exp Rheumatol"},{"issue":"11","key":"4063_CR36","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.3899\/jrheum.090572","volume":"36","author":"R Marquez-Velasco","year":"2009","unstructured":"Marquez-Velasco R, Rodriguez-Henriquez P, Bojalil R, Amezcua-Guerra LM (2009) Interleukin 6 is associated with pulmonary involvement in primary Sjogren\u2019s syndrome. J Rheumatol 36(11):2615\u20132616","journal-title":"J Rheumatol"},{"issue":"6","key":"4063_CR37","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1093\/rheumatology\/40.6.656","volume":"40","author":"J Hulkkonen","year":"2001","unstructured":"Hulkkonen J, Pertovaara M, Antonen J, Pasternack A, Hurme M (2001) Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in primary Sjogren\u2019s syndrome and correlate with the clinical manifestations of the disease. Rheumatology 40(6):656\u2013661","journal-title":"Rheumatology"},{"issue":"5","key":"4063_CR38","doi-asserted-by":"publisher","first-page":"R447-56","DOI":"10.1186\/ar1209","volume":"6","author":"M Bombardieri","year":"2004","unstructured":"Bombardieri M, Barone F, Pittoni V, Alessandri C, Conigliaro P, Blades MC et al (2004) Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sjogren\u2019s syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate. Arthritis Res Ther 6(5):R447-56","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"4063_CR39","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.2353\/ajpath.2009.090319","volume":"175","author":"GE Katsifis","year":"2009","unstructured":"Katsifis GE, Rekka S, Moutsopoulos NM, Pillemer S, Wahl SM (2009) Systemic and local interleukin-17 and linked cytokines associated with Sjogren\u2019s syndrome immunopathogenesis. Am J Pathol 175(3):1167\u20131177","journal-title":"Am J Pathol"},{"issue":"11","key":"4063_CR40","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/ng.2792","volume":"45","author":"CJ Lessard","year":"2013","unstructured":"Lessard CJ, Li H, Adrianto I, Ice JA, Rasmussen A, Grundahl KM et al (2013) Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjogren\u2019s syndrome. Nat Genet 45(11):1284\u20131292","journal-title":"Nat Genet"},{"issue":"1","key":"4063_CR41","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1172\/JCI0214121","volume":"109","author":"J Groom","year":"2002","unstructured":"Groom J, Kalled SL, Cutler AH, Olson C, Woodcock SA, Schneider P et al (2002) Association of BAFF\/BLyS overexpression and altered B cell differentiation with Sjogren\u2019s syndrome. J Clin Investig 109(1):59\u201368","journal-title":"J Clin Investig"},{"issue":"2","key":"4063_CR42","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1136\/ard.62.2.168","volume":"62","author":"X Mariette","year":"2003","unstructured":"Mariette X, Roux S, Zhang J, Bengoufa D, Lavie F, Zhou T et al (2003) The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjogren\u2019s syndrome. Ann Rheum Dis 62(2):168\u2013171","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"4063_CR43","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/rheumatology\/kes180","volume":"52","author":"L Quartuccio","year":"2013","unstructured":"Quartuccio L, Salvin S, Fabris M, Maset M, Pontarini E, Isola M et al (2013) BLyS upregulation in Sjogren\u2019s syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands. Rheumatology 52(2):276\u2013281","journal-title":"Rheumatology"},{"issue":"10","key":"4063_CR44","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1373\/clinchem.2009.129940","volume":"55","author":"L Pottier Le","year":"2009","unstructured":"Le Pottier L, Bendaoud B, Renaudineau Y, Youinou P, Pers JO, Daridon C (2009) New ELISA for B cell-activating factor. Clin Chem 55(10):1843\u20131851","journal-title":"Clin Chem"},{"issue":"4","key":"4063_CR45","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1002\/art.20998","volume":"52","author":"U Bave","year":"2005","unstructured":"Bave U, Nordmark G, Lovgren T, Ronnelid J, Cajander S, Eloranta ML et al (2005) Activation of the type I interferon system in primary Sjogren\u2019s syndrome: a possible etiopathogenic mechanism. Arthritis Rheumatol 52(4):1185\u20131195","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"4063_CR46","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1586\/1744666X.2014.876364","volume":"10","author":"Z Brkic","year":"2014","unstructured":"Brkic Z, Versnel MA (2014) Type I IFN signature in primary Sjogren\u2019s syndrome patients. Expert Rev Clin Immunol 10(4):457\u2013467","journal-title":"Expert Rev Clin Immunol"},{"issue":"21\u201322","key":"4063_CR47","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.1016\/j.febslet.2008.08.013","volume":"582","author":"WC HuangFu","year":"2008","unstructured":"HuangFu WC, Liu J, Harty RN, Fuchs SY (2008) Cigarette smoking products suppress anti-viral effects of Type I interferon via phosphorylation-dependent downregulation of its receptor. FEBS Lett 582(21\u201322):3206\u20133210","journal-title":"FEBS Lett"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-018-4063-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-018-4063-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-018-4063-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T19:06:50Z","timestamp":1559156810000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-018-4063-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,30]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["4063"],"URL":"https:\/\/doi.org\/10.1007\/s00296-018-4063-8","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,30]]},"assertion":[{"value":"4 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Regional Ethical Review Board for Southern Sweden (Lund, Sweden; LU 2012\/98). All patients gave written informed consent according to the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}]}}